Long Barrett's esophagus with early (multiple) cancer and high-grade dysplasia endoscopically resected: a case report and review of the literature

Authors

  • Denny Castro Centro de Control de Cáncer Gastrointestinal “Dr. Luis E Anderson”. San Cristóbal, Estado Táchira – Venezuela.
  • Vanessa Becerra Centro de Control de Cáncer Gastrointestinal “Dr. Luis E Anderson”. San Cristóbal, Estado Táchira – Venezuela.
  • Olga Silva Centro de Control de Cáncer Gastrointestinal “Dr. Luis E Anderson”. San Cristóbal, Estado Táchira – Venezuela.
  • Simón Peraza Centro de Control de Cáncer Gastrointestinal “Dr. Luis E Anderson”. San Cristóbal, Estado Táchira – Venezuela.

DOI:

https://doi.org/10.61155/2023.77.2.005

Keywords:

Barrett, esophagus, adenocarcinoma, dysplasia

Abstract

The incidence of adenocarcinoma (ADC) in patients with Barrett's esophagus (BE) is 0.3-0.6% patients/year, where said risk depends on the degree of dysplasia, being 7% in high-grade dysplasia. The present case consists of a 49-year-old male patient, with a history of long-legged Barrett's esophagus with high grade dysplasia, treated by endoscopic mucosal resection (EMR) with banding. He remains under rigorous follow-up, evidencing 3 years later, a tab in the distal esophagus, which underwent endoscopic treatment and was pathologically reported as a well-differentiated tubular adenocarcinoma with free margins; After 1 year, we observed a new lesion, flat and hyperemic, resected in the same way and reported as a well-differentiated adenocarcinoma with free margins. It remains under follow-up to date, with no new findings.

Downloads

Download data is not yet available.

References

Patel V, Burbridge RA. Endoscopic approaches for early-stage esophageal cancer: current options. Curr Oncol Rep. 2015;17(1):421.

Barret M, Prat F. Diagnosis and treatment of superficial esophageal cancer. Ann Gastroenterol. 2018;31(3):256-265.

Kim JA, Shah PM. Screening and prevention strategies and endoscopic management of early esophageal cancer. Chin Clin Oncol. 2017;6(5):50.

Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H; Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc. 2020;32(4):452-493.

Ahmed O, Ajani JA, Lee JH. Endoscopic management of esophageal cancer. World J Gastrointest Oncol. 2019;11(10):830-841

Mocanu A, Bârla R, Hoara P, Constantinoiu S. Current endoscopic methods of radical therapy in early esophageal cancer. J Med Life. 2015;8(2):150-6

Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20(9):71.

Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol. 2018;24(35):3965-3973.

Sanghi V, Amin H, Sanaka MR, Thota PN. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management. World J Gastrointest Endosc. 2019;11(10):491-503.

Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc. 2018;10(9):165-174

Shaheen NJ. ENDOSCOPIC TREATMENT OF ESOPHAGEAL NEOPLASIA: A DECADE OF EVOLUTION. Trans Am Clin Climatol Assoc. 2020; 131:297-314.

Leggett CL, Gorospe EC, Wang KK. Endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Clin North Am. 2013;42(1):175-85.

Published

2023-08-26

How to Cite

Castro, D., Becerra, V., Silva, O., & Peraza, S. (2023). Long Barrett’s esophagus with early (multiple) cancer and high-grade dysplasia endoscopically resected: a case report and review of the literature. Revista GEN, 77(2), 65–68. https://doi.org/10.61155/2023.77.2.005

Issue

Section

CLINICAL CASE

Most read articles by the same author(s)

1 2 3 > >>